Management of Ulcerative Colitis Using Vedolizumab After Liver Transplantation for Primary Sclerosing Cholangitis
- 8 October 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 10 (2) , 236
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Antitumor necrosis α treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantationLiver Transplantation, 2015
- Clinical management of inflammatory bowel disease in the organ recipientWorld Journal of Gastroenterology, 2014
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2013
- Anti‐tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipientsAlimentary Pharmacology & Therapeutics, 2012
- Inflammatory Bowel Disease After Liver Transplantation: Risk Factors for Recurrence and De Novo DiseaseAmerican Journal of Transplantation, 2006